Field Trip administers new synthetic molecule in Australia

Mugglehead
By Rowan DunneJul 22, 2022, 8:52 pm275 pts
At the Royal Adelaide Hospital in Australia, a new study is now underway that could potentially expand the catalogue of treatments available for individuals seeking psychoactive therapy. On Thursday, Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) announced that it had successfully administered the…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Controversial Ohio adult-use cannabis changes stall amid political dissension 65

Cannabis Means Business: 2025 Event Recap 46

Jungle Boys Opening 1st Arizona Dispensary in Phoenix 31

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.